To explore the effect of silymarin on NAFLD, relevant signaling pathways proteins (AKT1, IL-6, MAPK1, Caspase 3, p53, VEGFA) predicted by network pharmacology were investigated by Western blot (Figure 10). The gene discussed is MAPK1; the disease is metabolic dysfunction-associated steatotic liver disease.